Stroke Trial, Recruiting NCT03601702 Sponsor: Niguarda Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT03601702
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The person must agree to take part and sign a consent form
  • There must be a blockage in one of the major blood vessels supplying the brain, confirmed by a special scan (CTA or MRA), in specific locations in the front or back part of the brain's blood supply
  • A brain scan must show a score of 6 or higher on a measure used to assess how much of the brain may still be saved (confirm with trial site)
  • Scans must show that some brain tissue can still be rescued, either through a "mismatch" pattern or by showing that good backup blood flow pathways exist
  • The procedure to treat the blockage must begin within 12 hours of symptoms first starting
  • A specific medical device called the EmboTrap® II Revascularization Device must be used as the first or second treatment attempt to remove the blockage

Who may not be able to join:

  • People who have not given their consent to take part
  • People who have a blockage in a blood vessel outside the brain, or a combination of blockages in both the neck and brain vessels (called a tandem occlusion)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00396444

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Niguarda Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Safety: device -related haemorrhages rate showed by CT/MR; Efficacy: Restoration of cerebral blood flow at the end of the procedure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov